Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

The tech-heavy Nasdaq Composite rallied more than 9% this month. Information technology stocks are the top-performing sector ...

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

Major indices were little changed early on Wednesday as market participants awaited the release of minutes from the Federal ...

The S&P 500 Index ($SPX) (SPY) today is up +0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.19%, and the Nasdaq ...

Foot Locker (FL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Hormel Foods (HRL) reports results for the quarter ended April 2025. While this widely-known consensus outlook is ...

Revenue growth was driven by a substantial increase in episodic deliveries relative to last year’s strike-impacted March quarter, the company said, while the earnings decline reflected a ...